Chronic pain patients using spinal cord stimulators experienced pain relief, improvement in disability and sleep, and reduction in opioid use with fast-acting subperception therapy (FAST). The positive findings continued over a 12-month period.
A novel study published today in ADLM’s journal, Clinical Chemistry, has found that it takes the human body much longer than previously thought to clear xylazine — one of the most popular emerging drugs of abuse in the U.S. This much-needed insight into how the body processes xylazine could improve treatment of overdose patients who’ve taken it.
Study by Nemours Children's Health researcher finds 1 in 4 deaths of prenatally exposed infants involved caregivers who were both impaired and bed sharing at infant's time of death, suggests tailored messages to these caregivers are critical
Racial Differences in Opioid Use Disorder
New data shows overdose deaths continue to decline in the U.S. ...
Relief is coming for crime scene investigators and toxicologists who have struggled to accurately and swiftly identify drugs that have been seized by law enforcement and may be relied on as evidence at trial, thanks to a research partnership between West Virginia University and the U.S. Drug Enforcement Administration.
University of Maryland School of Medicine Researchers Identify Neurobiological Changes Leading to Increase Release of the Brain Chemical Dopamine and Its Target Neurons Linked to Addiction-Like Behavior With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety.
Scientists have identified a molecule that appears to restore normal breathing in mice following a large dose of fentanyl.
Health System to serve as a lead core enrollment site for diverse, national health database
Most U.S. military veterans who have used psychedelics reported in a recent study that they pursued the substances for healing or spiritual exploration, and over 80% said they benefited from the experience – even those who had challenging outcomes.
Hackensack Meridian JFK Johnson Rehabilitation Institute, a nationally recognized leader in physical medicine and rehabilitation, is proud to announce its participation in the upcoming American Academy of Physical Medicine And Rehabilitation Annual Assembly (AAPMR) 2024 Annual Assembly, taking place November 6-10 in San Diego, CA.
Scientists are developing ways to detect and identify not only new, previously unseen forms of fentanyl but also newer and more dangerous synthetic opioids known as nitazenes.
New Jersey Gov. Phil Murphy joined Rutgers and community leaders on Oct. 30 at the Child Health Institute in New Brunswick to celebrate a $47.5 million federal grant for the Rutgers Institute for Translational Medicine and Science that will improve health and well-being for New Jersey residents over the next seven years.
A collaborative study sheds light on how cannabis use affects brain development in young people, the main one being atrophy of certain regions of the cerebral cortex.
Among 88,183 U.S. high school students, marijuana use declined from 23.1% in 2011 to 15.8% in 2021, with first-time use before age 13 dropping from 8.1% to 4.9%. In 2021, use was highest among 12th graders (22.4%) and 11th graders (18.7%). Notably, girls (17.8%) surpassed boys (13.6%) in reported use in 2021, reversing past trends. While Asian, Hispanic, and white adolescents saw declines, Black adolescents had a higher usage rate of 20.5% in 2021, indicating ongoing racial disparities.
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that makers and marketers of prescription opioid painkillers misused scientific evidence to advance five common and inaccurate claims about the safety and effectiveness of prescription opioids—including that they were not addictive.
A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.
Researchers from WashU Medicine and Northwestern University developed an implantable device that can detect an overdose and rapidly deliver naloxone.
A team of Lawrence Livermore National Laboratory (LLNL) researchers has discovered a promising new treatment to counteract the effects of fentanyl and related opioids.
Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in overdose deaths from opioids combined with stimulant drugs other than cocaine, according to the results of a large federally funded study.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right